33-Year-Old Female with Adult Acne — Successfully Managed with Tretinoin, Clindamycin, and Spironolactone

Background

A 33-year-old female presented to Reena Jogi MD Dermatology in Katy, Texas for evaluation and management of moderate acne affecting the face. The patient reported a history of pimples and comedonal breakouts, which had persisted despite prior treatments, including a completed course of isotretinoin (Accutane).

She noted that her acne flared after discontinuing oral birth control pills. At the time of her visit, she was using tretinoin cream but continued to experience new inflammatory lesions.

Examination

A comprehensive skin examination, including facial and scalp evaluation, revealed:

  • Inflammatory papules and pustules

  • Comedonal papules concentrated on the cheeks and chin

  • No evidence of cystic or nodular lesions

  • Overall appearance consistent with hormonal acne

The patient appeared well-nourished and in no acute distress. A dermatoscope was used to closely assess the lesions and confirm the diagnosis.

Diagnosis

Clinical findings were consistent with adult female acne (L70.0) — a chronic inflammatory condition commonly associated with hormonal fluctuations, particularly around the menstrual cycle or after stopping birth control.

Treatment Plan

After reviewing her history and prior therapies, Dr. Reena Jogi recommended a comprehensive, multi-step acne regimen designed to reduce inflammation, prevent new breakouts, and improve long-term skin texture and tone.

Morning Routine

  • Clindamycin 1% lotion: Apply to affected areas every morning to decrease acne-causing bacteria and reduce redness.

  • Non-comedogenic moisturizer: Recommended brands include CeraVe Oil Control or EltaMD UV Clear SPF 46, which also provide sun protection for sensitive skin.

Learn more

Evening Routine

  • Tretinoin 0.05% cream: Apply a pea-sized amount to the entire face at bedtime, two to three times per week initially. Gradually increase to nightly use as tolerated.

    • Counseling: Wait 30 minutes after washing your face before applying tretinoin. Dry skin completely to reduce irritation.

  • Moisturizer: Apply a gentle, oil-free moisturizer afterward if dryness occurs.

Oral Therapy

  • Spironolactone 50 mg: Take one tablet twice daily to address hormonal causes of acne.

    • Side effects discussed: Breast tenderness, menstrual irregularities, fatigue, dizziness, and mild diuretic effect.

    • Precautions: Not for use during pregnancy; blood work may be required to monitor potassium levels in certain patients.

Patient Counseling

Dr. Jogi provided detailed counseling about acne management expectations:

  • Acne is a chronic condition that may require consistent treatment for months to maintain control.

  • Results take time: Most patients see a 60–80% improvement after 2–3 months of regular use.

  • Lifestyle habits: Use gentle, non-comedogenic products and avoid picking or squeezing lesions to prevent scarring.

  • Follow-up care: Patients should contact the clinic if acne worsens, new cysts or scarring develop, or side effects occur.

Discussion

This case highlights a common scenario of adult hormonal acne recurrence after stopping oral contraceptives, successfully managed with a combination of topical and oral therapies.

At Reena Jogi MD Dermatology in Katy and Houston, Texas, treatment plans are tailored to the individual’s skin type, history, and goals. The integration of retinoids, antibiotics, and hormonal therapy helps restore clear skin while minimizing long-term scarring and emotional distress.

Outcome

The patient began her regimen of tretinoin, clindamycin, and spironolactone with excellent adherence and understanding of potential side effects. A follow-up visit was scheduled in one year, with the option to return sooner for acne reassessment or treatment optimization.

Previous
Previous

37-Year-Old Female with Chronic Hair Shedding and Scalp Irritation — Telogen Effluvium and Seborrheic Dermatitis

Next
Next

Sudden Hair Shedding and Thinning in a 35-Year-Old Female — Telogen Effluvium and Early Androgenetic Alopecia